Microbiological and molecular characterization of commercially available probiotics containing Bacillus clausii from India and Pakistan

International Journal of Food Microbiology

Volumn 237, Issue , 2016, Pages 92-97

  Patrone, Vania ^a   Molinari, Paola ^a   Morelli, Lorenzo ^a  

^a UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

16S rRNA; Bacillus clausii; Denaturing gradient gel electrophoresis; Probiotics; Repetitive sequence based PCR

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; GENERIC DRUG; PROBIOTIC AGENT; RNA 16S;

ALCALIGENES FAECALIS; ARTICLE; BACILLUS; BACILLUS AMYLOLIQUEFACIENS; BACILLUS CEREUS; BACILLUS CLAUSII; BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS; BACTERIAL SPORE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; DRUG IDENTIFICATION; GENETIC VARIABILITY; GEOBACILLUS; INDIA; NONHUMAN; PAENIBACILLUS; PAKISTAN; PLATE COUNT; POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; STAPHYLOCOCCUS; XANTHOMONAS; BACTERIAL COUNT; BIFIDOBACTERIUM; CHEMISTRY; ECONOMICS; GENETICS; ISOLATION AND PURIFICATION; LACTOBACILLUS;

BACILLUS CLAUSII; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; INDIA; LACTOBACILLUS; PAKISTAN; POLYMERASE CHAIN REACTION; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 84982239100     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2016.08.012     Document Type: Article

References (40)

1. Aureli, P., Fiore, A., Scalfaro, C., Franciosa, G., Metodi microbiologici tradizionali e metodi molecolari per l'analisi ddegli integratori alimenatri a base di o con probiotici per uso umano. 2008 (Rapporti ISTISAN 08/36).
2. Boyle, R.J., Robins-Browne, R.M., Tang, M.L., Probiotic use in clinical practice: what are the risks?. Am. J. Clin. Nutr. 83 (2006), 1256–1264.
3. Brink, M., Senekal, M., Dicks, L.M.T., Market and product assessment of probiotic/prebiotic containing functional food and supplements manufactured in South Africa. S. Afr. Med. J. 95 (2005), 114–119.
4. Cenci, G., Trotta, F., Caldini, G., Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii. J. Appl. Microbiol. 101 (2006), 1208–1215.
5. De Vecchi, E., Nicola, L., Zanini, S., Drago, L., In vitro screening of probiotic characteristics of some Italian products. J. Chemother. 20 (2008), 341–347.
6. Di Cello, F.P., Fani, R., A molecular strategy for the study of natural bacterial communities by PCR-based techniques. Minerva Biotechnol. 8 (1996), 126–134.
7. Drisko, J., Bischoff, B., Giles, C., Adelson, M., Rao, R.V., McCallum, R., Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis. Dig. Dis. Sci. 50 (2005), 1113–1117.
8. Duc, L.H., Hong, H.A., Barbosa, T.M., Henriques, A.O., Cutting, S.M., Characterization of Bacillus probiotics available for human use. Appl. Environ. Microbiol. 70 (2004), 2161–2171.
9. Elliot, E., Teversham, K., An evaluation of nine probiotics available in South Africa, August 2003. S. Afr. Med. J. 94 (2004), 121–124.
10. European Food Safety Authority (EFSA), Scientific opinion on the substantiation of health claims related to non- characterised microorganisms pursuant to Article13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 7(9), 2009, 1247 Available at: http://www.efsa.europa.eu/it/efsajournal/pub/1247.
11. European Food Safety Authority (EFSA), Guidance on the assessment of the toxigenic potential of Bacillus species used in animal nutrition. EFSA Journal, 12(5), 2014, 3665 Available at: http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/3665.pdf.
12. Fasoli, S., Marzotto, M., Rizzotti, L., Rossi, F., Dellaglio, F., Torriani, S., Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int. J. Food Microbiol. 82 (2003), 59–70.
13. Floch, M.H., Recommendations for probiotic use in humans - a 2014 update. Pharmaceuticals (Basel) 7 (2014), 999–1007.
14. Food and Agricultural Organization of the United Nations and World Health Organization (FAO/WHO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf.
15. Ghelardi, E., Celandroni, F., Salvetti, S., Gueye, S.A., Lupetti, A., Senesi, S., Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. J. Appl. Microbiol. 119 (2015), 552–559.
16. Hao, Q., Dong, B.R., Wu, T., Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev., 2, 2015, CD006895.
17. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C., Sanders, M.E., Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 506–514.
18. Horosheva, T.V., Vitaly, V., Iryna, S., Efficacy of Bacillus probiotics in prevention of antibiotic-associated diarrhoea: a randomized, double-blind, placebo-controlled clinical trial. JMM Case Rep. 1 (2014), 1–6.
19. Huys, G., Botteldoorn, N., Delvigne, F., De Vuyst, L., Heyndrickx, M., Pot, B., Dubois, J.J., Daube, G., Microbial characterization of probiotics–advisory report of the Working Group “8651 Probiotics” of the Belgian Superior Health Council (SHC). Mol. Nutr. Food Res. 57 (2013), 1479–1504.
20. Indian Council of Medical Research and Department of Biotechnology (ICMR-DBT), 2011. Guidelines for evaluation of probiotics in food. Available at: http://icmr.nic.in/guide/PROBIOTICS_GUIDELINES.pdf.
21. Ishibashi, N., Yamazaki, S., Probiotics and safety. Am. J. Clin. Nutr. 73 (2001), 465S–470S.
22. Lippolis, R., Siciliano, R.A., Mazzeo, M.F., Abbrescia, A., Gnoni, A., Sardanelli, A.M., Papa, S., Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains. Proteome Sci., 11, 2013, 28.
23. Marcobal, A., Underwood, M.A., Mills, D.A., Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis. J. Pediatr. Gastroenterol. Nutr. 46 (2008), 608–611.
24. Masco, L., Huys, G., De Brandt, E., Temmerman, R., Swings, J., Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int. J. Food Microbiol. 102 (2005), 221–230.
25. Miquel, S., Beaumont, M., Martin, R., Langella, P., Braesco, V., Thomas, M., A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb. Cell Factories, 14, 2015, 48.
26. Sanders, M.E., Probiotics: considerations for human health. Nutr. Rev. 61 (2003), 91–99.
27. Sanders, M.E., Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 46:Suppl. 2 (2008), S58–S61 (discussion S144-151).
28. Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., Sherman, P.M., Mayer, E.A., An update on the use and investigation of probiotics in health and disease. Gut 62 (2013), 787–796.
29. Saxelin, M., Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective. Clin. Infect. Dis. 46:Suppl. 2 (2008), S76–S79 (discussion S144-151).
30. Senesi, S., Celandroni, F., Tavanti, A., Ghelardi, E., Molecular characterization and identification of Bacillus clausii strains marketed for use in oral bacteriotherapy. Appl. Environ. Microbiol. 67 (2001), 834–839.
31. Sorokulova, I.B., Pinchuk, I.V., Denayrolles, M., Osipova, I.G., Huang, J.M., Cutting, S.M., Urdaci, M.C., The safety of two Bacillus probiotic strains for human use. Dig. Dis. Sci. 53 (2008), 954–963.
32. Sudha, M.R., Bhonagiri, S., Kumar, M.A., Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea. Benefic. Microbes 4 (2013), 211–216.
33. Sul, S.Y., Kim, H.J., Kim, T.W., Kim, H.Y., Rapid identification of Lactobacillus and Bifidobacterium in probiotic products using multiplex PCR. J. Microbiol. Biotechnol. 17 (2007), 490–495.
34. Szajewska, H., Fordymacka, A., Bardowski, J., Gorecki, R.K., Mrukowicz, J.Z., Banaszkiewicz, A., Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med. Sci. Monit. 10 (2004), BR346–BR350.
35. Theunissen, J., Britz, T.J., Torriani, S., Witthuhn, R.C., Identification of probiotic microorganisms in South African products using PCR-based DGGE analysis. Int. J. Food Microbiol. 98 (2005), 11–21.
36. van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., Brummer, R.J., Probiotic and synbiotic safety in infants under two years of age. Benefic. Microbes 5 (2014), 45–60.
37. van den Nieuwboer, M., Brummer, R.J., Guarner, F., Morelli, L., Cabana, M., Claassen, E., Safety of probiotics and synbiotics in children under 18 years of age. Benefic. Microbes 6 (2015), 615–630.
38. Venugopalan, V., Shriner, K.A., Wong-Beringer, A., Regulatory oversight and safety of probiotic use. Emerg. Infect. Dis. 16 (2010), 1661–1665.
39. Versalovic, J., Schneider, M., de Bruijn, F.J., Lupski, J.R., Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Method. Mol. Cell. Biol. 5 (1994), 25–40.
40. Yeung, P.S., Sanders, M.E., Kitts, C.L., Cano, R., Tong, P.S., Species-specific identification of commercial probiotic strains. J. Dairy Sci. 85 (2002), 1039–1051.